Table 1.
Disease | Individuals | Heart Cores Evaluated | % Male | % Caucasian | Age (±SD) |
---|---|---|---|---|---|
Control | 245 | 284 | 61.3% | 76.5% | 54.7 ± 16.4 |
SCD + CAD - Thrombosis | 118 | 133 | 85.7% | 69.6% | 55.8 ± 10.8 |
SCD - CAD | 85 | 91 | 68.1% | 57.5% | 48.4 ± 13.6 |
SCD + CAD + Thrombosis | 70 | 83 | 85.5% | 68.8% | 48.0 ± 10.1 |
HCM | 55 | 59 | 52.5% | 69.5% | 54.9 ± 13.7 |
DCM | 41 | 45 | 64.4% | 42.2% | 55.9 ± 13.8 |
IHD | 34 | 35 | 71.4% | 85.7% | 61.0 ± 9.1 |
ACM | 9 | 14 | 71.4% | 72.7% | 42.6 ± 12.4 |
Pediatric Congenital | 8 | 8 | 50.0% | 50.0% | 3.9 ± 3.4 |
Othera | 14 | 15 | 53.3% | 35.7% | 51.8 ± 12.5 |
Key. SCD = Sudden Cardiac Death; CAD = Coronary Artery Disease; CM = Cardiomyopathy; aincludes cardiomegaly, chronic active myocarditis, right heart failure, noncompaction cardiomyopathy, retransplant, sarcoidosis, and other unclassified disease.